Last reviewed · How we verify
NCT06199128: Fix
Efficacy and Safety of Carboxymethyl Beta-glucan and Policarbophil in HPV Positive Patients
trial testing carboxymethyl β-glucan in Human Papillomavirus Infection in 533 participants. Completed in 22 November 2023.
22 September 2023
Quick facts
| Lead sponsor | Uriach Consumer Healthcare |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 533 |
| Start date | 22 September 2022 |
| Primary completion | 22 September 2023 |
| Estimated completion | 22 November 2023 |
| Sites | 5 locations across Spain |
Drugs / interventions tested
- carboxymethyl β-glucan
Conditions studied
- Human Papillomavirus Infection — all drugs for Human Papillomavirus Infection →
Sponsor
Uriach Consumer Healthcare
Who can join
Adults 25 to 65, female only, with Human Papillomavirus Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Prospective, Controlled, Multicentre, Real Clinical Practice Study. Effectiveness of Carboxymethyl β-Glucan treatment in high-risk HPV+ patients
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06199128
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Human Papillomavirus Infection
Currently open trials in the same condition.
- NCT07281430 — Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04) · NA · recruiting
- NCT06598475 — Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve · NA · recruiting
- NCT06611553 — Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02) · NA · active not recruiting
- NCT06611540 — Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03) · NA · active not recruiting
- NCT06498661 — Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01) · NA · recruiting
Other Uriach Consumer Healthcare trials
Trials by the same sponsor.
- NCT05459272 — Clinical Trial on a Food Supplement With Melatonin and Herbal Products to Improve Sleep Quality · NA · unknown
- NCT05060744 — Efficacy and Speed of Action of a Product to Control Gastric Hydration and Gastroesophageal Reflux · NA · unknown
- NCT04771546 — Efficacy of Intravaginal Carboxymethyl-β-glucan and Polycarbophil on Low-grade Cervical Lesions (GLUCANCIN) · NA · unknown
- NCT04781023 — Efficacy of an Intravaginal Treatment With Carboxymethyl-β-glucan and Polycarbophil in HR-HPV Clearance · NA · unknown
- NCT06324760 — Alpha-lipoic Acid Combined With B Vitamins Shows Promise for Treating Restless Legs Syndrome · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06199128 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Uriach Consumer Healthcare
- Last refreshed: 10 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06199128.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing